News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,128 Results
Type
Article (52038)
Company Profile (413)
Press Release (675677)
Section
Business (213426)
Career Advice (2201)
Deals (37694)
Drug Delivery (103)
Drug Development (85275)
Employer Resources (173)
FDA (16863)
Job Trends (15629)
News (362933)
Policy (34803)
Tag
Academia (2783)
Alliances (52348)
Alzheimer's disease (1271)
Approvals (16767)
Artificial intelligence (136)
Bankruptcy (373)
Best Places to Work (11807)
Biotechnology (279)
Breast cancer (119)
Cancer (1044)
Career advice (1844)
Cell therapy (240)
Clinical research (67164)
Collaboration (362)
Compensation (175)
COVID-19 (2697)
C-suite (92)
Data (958)
Diabetes (144)
Diagnostics (6323)
Drug pricing (92)
Earnings (86770)
Employer resources (152)
Events (114410)
Executive appointments (267)
FDA (17340)
Funding (312)
Gene therapy (174)
GLP-1 (633)
Government (4576)
Healthcare (19310)
Infectious disease (2779)
Inflammatory bowel disease (111)
Interviews (350)
IPO (16752)
Job creations (4160)
Job search strategy (1569)
Layoffs (458)
Legal (8563)
Lung cancer (176)
Manufacturing (180)
Medical device (13487)
Medtech (13492)
Mergers & acquisitions (20967)
Metabolic disorders (407)
Neuroscience (1539)
NextGen Class of 2024 (6865)
Non-profit (4639)
Northern California (1330)
Obesity (241)
Opinion (216)
Patents (104)
People (59038)
Pharmaceutical (101)
Phase I (20903)
Phase II (29503)
Phase III (22098)
Pipeline (326)
Postmarket research (2734)
Preclinical (9180)
Radiopharmaceuticals (251)
Rare diseases (209)
Real estate (6385)
Regulatory (22964)
Research institute (2509)
Resumes & cover letters (377)
Southern California (1179)
Startups (3842)
United States (12720)
Vaccines (591)
Weight loss (189)
Date
Today (241)
Last 7 days (1117)
Last 30 days (3440)
Last 365 days (36904)
2024 (32468)
2023 (41344)
2022 (52648)
2021 (57216)
2020 (55699)
2019 (48524)
2018 (36741)
2017 (34168)
2016 (33858)
2015 (39827)
2014 (33710)
2013 (29300)
2012 (31305)
2011 (31767)
2010 (29915)
Location
Africa (837)
Arizona (199)
Asia (41983)
Australia (6967)
California (3021)
Canada (1216)
China (231)
Colorado (134)
Connecticut (135)
Europe (90819)
Florida (422)
Georgia (105)
Illinois (336)
Indiana (197)
Kansas (99)
Maryland (565)
Massachusetts (2487)
Michigan (147)
Minnesota (261)
New Jersey (891)
New York (893)
North Carolina (716)
Northern California (1330)
Ohio (130)
Pennsylvania (792)
South America (1242)
Southern California (1179)
Texas (421)
Washington State (353)
728,128 Results for "cell pathways inc acquired by osi pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OSI Systems Reports Fiscal 2024 Third Quarter Financial Results
OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the three and nine months ended March 31, 2024.
April 25, 2024
·
15 min read
Deals
Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.
Future Pak, LLC and its affiliates announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. in a good faith effort to acquire all outstanding shares of Vanda.
June 13, 2024
·
4 min read
Press Releases
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
October 3, 2024
·
8 min read
Press Releases
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT’s 2024 Advancing Gene and Cell Therapies for Cancer Conference
PH-894: Potent and Specific Silencing of BRD4 in NK Cells
October 16, 2024
·
4 min read
Biotech Bay
EditCo Bio, Inc. Expands Primary Cell Portfolio with Launch of Knockout CD8+ T-cell Pools
EditCo Bio, Inc., a leader in genome engineering innovation, announced the expansion of its T-cell editing portfolio with the launch of Knockout CD8+ T-cell Pools.
June 27, 2024
·
2 min read
FDA
Evolving FDA Accelerated Approval Pathway Suffers Spate of Withdrawals
As therapies for rare and neurological diseases earn accelerated approval, experts laud the program’s intent while remaining concerned about confirmatory trials and clinical efficacy, especially as products greenlit under this pathway are pulled from the market.
October 28, 2024
·
7 min read
·
Heather McKenzie
Biotech Bay
10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
10x Genomics, Inc., a leader in single cell and spatial biology, announced that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel.
June 20, 2024
·
5 min read
Proteologix, Inc. to be Acquired by Johnson & Johnson
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson
May 16, 2024
·
2 min read
Biotech Beach
OSI Systems Receives $5 Million Award for Patient Monitoring Solutions
OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $5 million to provide patient monitoring solutions and related supplies and accessories to a U.S. based hospital.
January 4, 2024
·
2 min read
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
1 of 72,813
Next
